Corcept Therapeutics | CORT - Cost Of Sales

Stock Price
40.82
Daily Change
2.46 6.41%
Monthly
10.32%
Yearly
-39.98%
Q1 Forecast
38.64

Corcept Therapeutics reported $4.6M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 21.65M 913K Sep/2025
Alaunos Therapeutics USD 0 18K Sep/2024
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Ardelyx USD 3.98M 10.84M Sep/2025
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
BioMarin Pharmaceutical USD 144.93M 10M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Corcept Therapeutics USD 4.6M 1.16M Sep/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
J&J USD 7.97B 689M Dec/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Novartis USD 3.54B 216M Sep/2025
Pacira USD 48.6M 6.59M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Supernus Pharmaceuticals USD 43.29M 5.64M Sep/2025
TG Therapeutics USD 28.09M 9.15M Sep/2025